Clayson PE, Joshi YB, Thomas ML, Tarasenko M, et al. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophr Res 2021 Jun 26. pii: S0920-9964(21)00234.
PMID: 34187732